Evidentli
Evidentli is a medical software company.
Backed by
EQUITY on April 13, 2023
About
Evidentli provides Piano, an AI/ML platform that extracts evidence from diverse healthcare data to accelerate clinical evidence generation and support decision-making across research teams on multiple continents.
Mission
Evidentli's flagship product, Piano, leverages AI and machine learning to extrapolate insights from healthcare data to inform evidence-based decisions far more quickly than traditional research teams. The platform is positioned to address the gap the company describes as healthcare being ""data-rich but evidence-poor."" Investible announced it welcomed Guy Tsafnat PhD FAIDH, Enrico Coiera, Alison Gartner, Greg Miner and the whole Evidentli team into its portfolio at the end of last year. Investible's Early Stage Fund 2 and Club Investible participated in the investment alongside Black Nova Venture Capital, Australian Medical Angels, Healthcare Ventures LP and HNW investors. Evidentli says it is now operating on four continents and is growing quickly. The company highlights ongoing support from Investible as part of its expansion.
Quick Facts
Founded
2018
Funding
EQUITY
Industry
Health Care, Medical, Software
Team Size
11-50
Headquarters
Sydney, New South Wales, Australia
Careers
View Careers PageEvidentli
https://jobs.ashbyhq.com/evidentliNo open roles at this time.
Check their careers page for updates